For a few years, a 22-year-old resident of Israel suffered from an extraordinary illness: each and every time after orgasm he had signs of influenza-weakness, headache, runny nostril and top fatigue. Once in a while he felt so dangerous that he may just no longer assume and paintings usually, Liter.kz studies as regards to BILD. … Read more
Medicine rating board is a complete waste of money Vienna (OTS) – “The ‘assessment board for selected drug specialties’ introduced in the Ministry of Health under the Green Minister Rauch is still nothing more than a ‘death commission’ that decides whether to live or die. The fatal thing about this institution is that out of … Read more
Study highlights risks of the planned pharmaceutical legislation for drug research, investments and healthcare in Europe. Vienna (OTS) – The planned reform of the EU pharmaceutical legislation is intended to make access to medicines fairer, make the supply of medicines safer and make Europe more competitive. Whether this can be achieved with the measures defined … Read more
The EU HTA regulation anchors a uniform clinical assessment of new therapies in Europe and has consequences for access to new therapies in Austria. We as the pharmaceutical industry want a high-quality, streamlined and transparent process. The cooperation of all actors in the health system at the national level is crucial to ensure the early … Read more
New scientific institutes increase focus on health research. Drug development can benefit from this. The new research facilities represent an important stimulus for health research in Austria. This will expand the research infrastructure in Austria. This in turn is an extremely welcome sign beyond Austria’s borders and contributes to its international positioning as a location … Read more
Current study reveals hurdles in accessing innovative therapies in private practice. At the same time, research has a positive effect on this approach. Innovative therapies can only work if they are accessible to patients. Where this is prevented by barriers in the reimbursement system, we urgently need this system to be further developed to make … Read more
SPÖ wants to repair the current legal regulation with an upper cost limit for medicines Vienna (OTS/SK) – SPÖ Ombudsman spokesman Rudolf Silvan renews the SPÖ’s demand for the introduction of a drug cost cap. SPÖ health spokesman Philip Kucher has submitted a corresponding application. However, the government parties did not approve the application in … Read more
Vice President of the Austrian Medical Association: Novartis’ investments in the Tyrol location and expansion of biopharmaceutical production are exemplary for Europe. Vienna (OTS) – “Investments in Austria as a pharmaceutical location are a strong signal for independent and independent drug production in our country,” said Harald Mayer, Vice President of the Austrian Medical Association … Read more
Worldwide Operation SHIELD IV continues to show strong demand for illegal pharmaceutical preparations – PHARMIG warns of their fatal consequences for health The goods confiscated during the operation show us that the illegal trade in counterfeit medicines and other preparations continues to thrive. The dealers are unscrupulous, as the counterfeit medicines threaten the health and … Read more
